Orris

Low flow anaesthesia 5 mark answer

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I now have enough material for a comprehensive 5-mark answer. Let me compile it.

Low Flow Anaesthesia

Definition

Low flow anaesthesia (LFA) refers to a technique in which the fresh gas flow (FGF) is set at less than 1 L/min into a circle breathing system, such that the FGF is far less than the patient's minute ventilation and at least 50% of expired gas is rebreathed after CO2 removal by the absorber. When FGF is reduced to ≤0.5 L/min, it is termed minimal flow anaesthesia. In a truly closed-circuit system, oxygen inflow exactly matches metabolic consumption, rebreathing is complete, and no gas is vented.
(Miller's Anesthesia, 10e)

Classification by Fresh Gas Flow Rate

TypeFGF
High / semi-open> 4 L/min
Medium flow1-4 L/min
Low flow< 1 L/min
Minimal flow≤ 0.5 L/min
Closed circuit= metabolic O2 uptake (~250 mL/min)

Requirements / Prerequisites

  1. Circle system with unidirectional valves - mandatory to allow controlled rebreathing.
  2. CO2 absorber (soda lime / Drägersorb) - to remove exhaled CO2 from rebreathed gas.
  3. Calibrated vaporizer - accurate delivery at low flows.
  4. Oxygen analyser on the inspiratory limb - since the inspired O2 concentration may become hypoxic if FGF is insufficient to replace metabolic O2 consumption.
  5. Capnograph and gas analyser - to monitor inspired and end-tidal concentrations; N2 build-up can be detected.

Advantages

  1. Reduced drug consumption - significantly less volatile agent and nitrous oxide used, lowering cost.
  2. Environmental benefit - less greenhouse gas pollution from volatile agents vented to atmosphere.
  3. Improved humidification and warmth - rebreathed gases are warm and humidified, preserving airway mucosal function and reducing heat loss.
  4. Reduced cost - both agent and gas (O2, N2O) usage are lower.
  5. Early warning of circuit leaks - at very low FGF, any leak in the circuit manifests quickly as a fall in airway pressure or volume.
(Miller's Anesthesia, 10e; Barash Clinical Anesthesia, 9e)

Disadvantages / Hazards

  1. Difficulty titrating depth - changes in vaporizer dial setting take longer to alter inspired concentration when FGF is low; slower washout of agents on emergence.
  2. Risk of hypoxic mixture - if O2 flow is less than metabolic demand, the inspired O2 fraction falls; continuous FiO2 monitoring is mandatory.
  3. Accumulation of unwanted gases - exhaled endogenous gases (carbon monoxide, acetone, methane) and degradation products can accumulate.
  4. Compound A formation with sevoflurane - sevoflurane is degraded by CO2 absorbents (especially dry barium hydroxide lime) to compound A (fluoromethyl-2,2-difluoro-1-[trifluoromethyl]vinyl ether), a nephrotoxic vinyl ether. Production is enhanced at low/closed-circuit flows. Inspired concentrations average 8-32 ppm in clinical practice; however, clinical studies have found no adverse renal effects in humans, and compound A is currently not considered a clinically significant concern. Some guidelines recommend maintaining FGF ≥2 L/min for sevoflurane anesthetics lasting more than a few hours.
  5. Carbon monoxide (CO) production - desflurane and isoflurane can be degraded to CO by desiccated CO2 absorbents containing strong bases (KOH/NaOH); cases of CO poisoning have been reported. This risk is eliminated with modern absorbents (e.g., Amsorb Plus) free of strong bases.
  6. Nitrogen accumulation - particularly if denitrogenation is incomplete at induction; can dilute the O2/agent mixture.
(Barash Clinical Anesthesia, 9e; Morgan & Mikhail's Clinical Anesthesiology, 7e; Miller's Anesthesia, 10e)

Sevoflurane and Compound A - Key Points

  • Compound A formation is enhanced by: (1) low-flow or closed-circuit technique, (2) dry/warm absorbent, (3) high sevoflurane concentration, (4) long duration.
  • Most countries have no mandatory FGF floor for sevoflurane given the absence of clinical renal toxicity.
  • Using absorbents without strong bases (e.g., calcium hydroxide-based, Amsorb) reduces compound A generation and allows LFA with sevoflurane safely.

Closed-Circuit Anaesthesia

The most extreme form: FGF = metabolic O2 (~250 mL/min). Agent is added in liquid form or titrated via vaporizer. It maximizes all the benefits of low-flow technique but demands intense vigilance and gas monitoring, making it impractical for routine use.

Summary for 5 Marks

Low flow anaesthesia (<1 L/min FGF in a circle system) offers significant economic, ecological, and physiological advantages (reduced agent use, better humidification, less pollution) but requires a fully functional circle absorber system, continuous O2 analysis, and careful vigilance for hypoxic mixtures, CO accumulation, and - with sevoflurane - compound A generation. Target-controlled inhalational anaesthesia systems (Dräger, GE, Maquet) now automate flow titration to maintain desired end-tidal agent concentration, realizing the benefits of LFA without manual complexity.
This is a shared conversation. Sign in to Orris to start your own chat.